Skip to content

Christos Socrates Mantzoros, MD

NPI 1275512808ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Boston, MA

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Boston, Massachusetts, licensed in MA, with an NPI issued in January 2006. Boehringer Ingelheim Pharmaceuticals, Inc. was the largest of 8 companies reporting payments in 2025, $123,837 in all, mostly consulting fees.

Overview

NPI1275512808
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJan 12, 2006
Last updated in NPPESJul 13, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$123,837 · 92 payments from 8 companies
  • 2024$34,583 · 49 payments from 8 companies

Top paying companies in 2025

What the 2025 payments were for

  • Consulting Fee$99,955 · 22 payments
  • Travel and Lodging$13,000 · 37 payments
  • Honoraria$5,700 · 2 payments
  • Compensation for serving as faculty or as a speaker for a medical education program$3,049 · 1 payment
  • Food and Beverage$2,133 · 30 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Boston

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Massachusetts →